<?xml version="1.0" encoding="UTF-8"?><!-- Generated by Broadridge Transform (tm) - http://www.broadridge.com --><!-- Created: Wed Nov 18 00:08:10 UTC 2026 --><edgarSubmission xmlns="http://www.sec.gov/edgar/ownership" xmlns:common="http://www.sec.gov/edgar/common" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <headerData>
    <submissionType>144</submissionType>
    <filerInfo>
      <filer>
        <filerCredentials>
          <cik>0001950501</cik>
          <ccc>XXXXXXXX</ccc>
        </filerCredentials>
      </filer>
      <liveTestFlag>LIVE</liveTestFlag>



    </filerInfo>
  </headerData>
  <formData>
    <issuerInfo>
      <issuerCik>0001781174</issuerCik>
      <issuerName>Acrivon Therapeutics, Inc.</issuerName>
      <secFileNumber>001-41551</secFileNumber>
      <issuerAddress>
        <common:street1>c/o Acrivon Therapeutics, Inc.</common:street1>
        <common:street2>480 Arsenal Way, Suite 100</common:street2>
        <common:city>Watertown</common:city>
        <common:stateOrCountry>MA</common:stateOrCountry>
        <common:zipCode>02472</common:zipCode>
      </issuerAddress>
      <issuerContactPhone>617-207-8979</issuerContactPhone>
      <nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>Kristina Masson</nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>
      <relationshipsToIssuer>
        <relationshipToIssuer>Officer</relationshipToIssuer>
        <relationshipToIssuer>Director</relationshipToIssuer>
      </relationshipsToIssuer>
    </issuerInfo>
    <securitiesInformation>
      <securitiesClassTitle>Common Stock</securitiesClassTitle>
      <brokerOrMarketmakerDetails>
        <name>Morgan Stanley Smith Barney LLC</name>
        <address>
          <common:street1>Executive Services</common:street1>
          <common:street2>200 W Civic Center Drive, 4th Floor</common:street2>
          <common:city>Sandy</common:city>
          <common:stateOrCountry>UT</common:stateOrCountry>
          <common:zipCode>84070</common:zipCode>
        </address>
      </brokerOrMarketmakerDetails>
      <noOfUnitsSold>504</noOfUnitsSold>
      <aggregateMarketValue>720.72</aggregateMarketValue>
      <noOfUnitsOutstanding>42911680</noOfUnitsOutstanding>
      <approxSaleDate>11/17/2026</approxSaleDate>
      <securitiesExchangeName>NASDAQ</securitiesExchangeName>
    </securitiesInformation>
    <securitiesToBeSold>
      <securitiesClassTitle>Common Stock</securitiesClassTitle>
      <acquiredDate>11/14/2026</acquiredDate>
      <natureOfAcquisitionTransaction>Settlement of vested RSUs issued under an S-8 Registration Plan</natureOfAcquisitionTransaction>
      <nameOfPersonfromWhomAcquired>Issuer</nameOfPersonfromWhomAcquired>
      <isGiftTransaction>N</isGiftTransaction>
      <amountOfSecuritiesAcquired>1670</amountOfSecuritiesAcquired>
      <paymentDate>11/14/2026</paymentDate>
      <natureOfPayment>Equity compensation for services rendered</natureOfPayment>
    </securitiesToBeSold>
    <nothingToReportFlagOnSecuritiesSoldInPast3Months>N</nothingToReportFlagOnSecuritiesSoldInPast3Months>
    <securitiesSoldInPast3Months>
      <sellerDetails>
        <name>Peter Blume-Jensen</name>
        <address>
          <common:street1>480 Arsenal Way</common:street1>
          <common:street2>Suite 100</common:street2>
          <common:city>Watertown</common:city>
          <common:stateOrCountry>MA</common:stateOrCountry>
          <common:zipCode>02472</common:zipCode>
        </address>
      </sellerDetails>
      <securitiesClassTitle>Common Stock</securitiesClassTitle>
      <saleDate>08/18/2026</saleDate>
      <amountOfSecuritiesSold>1229</amountOfSecuritiesSold>
      <grossProceeds>2470.29</grossProceeds>
    </securitiesSoldInPast3Months>
    <securitiesSoldInPast3Months>
      <sellerDetails>
        <name>Kristina Masson</name>
        <address>
          <common:street1>480 Arsenal Way</common:street1>
          <common:street2>Suite 100</common:street2>
          <common:city>Watertown</common:city>
          <common:stateOrCountry>MA</common:stateOrCountry>
          <common:zipCode>02472</common:zipCode>
        </address>
      </sellerDetails>
      <securitiesClassTitle>Common Stock</securitiesClassTitle>
      <saleDate>08/18/2026</saleDate>
      <amountOfSecuritiesSold>484</amountOfSecuritiesSold>
      <grossProceeds>972.84</grossProceeds>
    </securitiesSoldInPast3Months>
    <securitiesSoldInPast3Months>
      <sellerDetails>
        <name>Peter Blume-Jensen</name>
        <address>
          <common:street1>480 Arsenal Way</common:street1>
          <common:street2>Suite 100</common:street2>
          <common:city>Watertown</common:city>
          <common:stateOrCountry>MA</common:stateOrCountry>
          <common:zipCode>02472</common:zipCode>
        </address>
      </sellerDetails>
      <securitiesClassTitle>Common Stock</securitiesClassTitle>
      <saleDate>08/25/2026</saleDate>
      <amountOfSecuritiesSold>14036</amountOfSecuritiesSold>
      <grossProceeds>30969.08</grossProceeds>
    </securitiesSoldInPast3Months>
    <remarks>Shares sold automatically to satisfy the mandatory tax withholding requirement upon vesting of restricted stock units. These securities were sold by the Issuer's co-founder and EVP, Dr. Kristina Masson. The table of securities sold during the past 3 months includes sales by each of Dr. Kristina Masson and her spouse, Dr. Peter Blume-Jensen, who is also a director and officer of the Issuer.</remarks>
<!-- [WMV7][W5mSLZeFz85W1g1SRstya5/IByIoxI8XNVC/1C0vaIdYrQT9+/lgYJwD6hVbYs/vq/8CbQdK8KT7XNkADoQktJLF7svkG3TPVSqkY16uTpEnkff0H/q/dxRFLkVE57aRv0Q2YkiZjSxNRQcUTCHlKD0Jm2ilGKfy8o4OiPIdwYpkSQWjOD7dm7CJdBxvDUz82jn7EKlLyBLanptSXNlzS3fRP+TUBn9/tpQHc8M4wL2orUAIvihmTgp8X/FVyPMNU3He0McFYWuetWJ6fq/Wqn97KzDNTaZKn8aU9A1YgDIoBYNpBmGxfsSqRE45S8oOlOnXp87WosKknotdDUOhSutvd3stjIhkIJ9fxF9hNtdR] CSR-->
    <noticeSignature>
      <noticeDate>11/17/2026</noticeDate>
      <signature>/s/ Adam D. Levy, Attorney-in-Fact</signature>
    </noticeSignature>
  </formData>
</edgarSubmission>
